Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: A prospective study

Gastroenterology

Volumn 108, Issue 3, 1995, Pages 812-817

  Borzio, Mauro ^a   Bruno, Savino ^b   Roncalli, Massimo ^b   Colloredo Mels, Guido ^c   Ramella, Giorgio ^d   Borzio, Franco ^a   Leandro, Gioacchino ^e   Servida, Ernesto ^a   Podda, Mauro ^b  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b Europ Sch of Transfusion Medicine   (Italy)

^c BOLOGNINI HOSPITAL   (Italy)

^d Ospedale Predabissi   (Italy)

^e Castellana Grotte Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; CANCER RISK; DISEASE ASSOCIATION; DYSPLASIA; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

EID: 0028958050     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(95)90455-7     Document Type: Article

References (36)

1. Liver cell dysplasia: a premalignant condition
2. Clinical pathological studies of liver cirrhosis and hepatocellular carcinoma in a general hospital
3. Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong
4. Morphologic studies of the liver cell dysplasia
5. Liver cell dysplasia in cirrhosis: a serologic and immunoistochemical study
6. Liver cell dysplasia in normal, cirrhotic and hepatocellular carcinoma patients
7. Biologic behaviour of dysplasia and carcinoma in situ
8. Hepatocarcinogenesis: a dynamic cellular perspective
9. Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma
10. Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma
11. Hepatitis B virus antigens in liver tissue in hepatocellular carcinoma and advanced chronic liver disease
12. Pathology of hepatocellular carcinoma in Japan: 232 consecutive cases autopsied in ten years
13. Adenomatous hyperplasia of the liver as a precancerous lesion
14. Liver cell dysplasia and risk of hepatocellular carcinoma in cirrhosis: a preliminary report
15. The morphology of cirrhosis
16. Histological typing of tumors of the liver, biliary tract and pancreas
17. An assay for circulating antibodies to a major etiologic virus of human non-A non-B hepatitis
18. The measurement of observer agreement for categorical data
19. Nonparametric estimation from incomplete observations
20. Regression models and life-tables
21. Liver cell dysplasia and hepatocellular carcinoma: a histologic and immunohistochemical study
22. A morphometric study of liver cell dysplasia
23. Abnormal DNA content in liver cell dysplasia: a flow cytometric study
24. Liver cell dysplasia: a DNA aneuploid lesion with distinct morphologic features
25. A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection
26. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan
27. Relative risks of death due to liver disease among Japanese male adults having various statuses of hepatitis B s and e antigen/antibody in serum: a prospective study
28. Risk factors for hepatocellular carcinoma among patients with chronic liver disease
29. Risk factors in development of hepatocellular carcinoma in cirrhosis
30. Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status and aetiology of underlying cirrhosis
31. Hepatocellular carcinoma in Italian patients with cirrhosis
32. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis
33. Does hepatitis C virus cause hepatocellular carcinoma?
34. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications
35. Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alphafetoprotein: a prospective study
36. Hepatocellular carcinoma: recent progress